Induction of calprotectin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils.
Calprotectin, a major cytosolic protein of leukocytes, is detected in neutrophils, monocytes/macrophages, and epithelial cells. This protein is known to be a marker for several inflammatory diseases and is detected in inflammatory gingival tissue with periodontal disease. Recently, we found that the calprotectin level in gingival crevicular fluid from periodontitis patients was significantly higher than that of healthy subjects. However, the regulation of calprotectin in periodontal disease is unclear. In the present study, we investigated the effect of lipopolysaccharides of periodontopathic bacteria on calprotectin release from human neutrophils. Neutrophils from healthy donors were treated with lipopolysaccharides from Porphyromonas gingivalis (P-LPS), Actinobacillus actinomycetemcomitans, Prevotella intermedia, Fusobacterium nucleatum, and Escherichia coli. Calprotectin of neutrophil was identified by immunoblotting and calprotectin amount was determined by ELISA. Two subunits (10 and 14 kDa) of calprotectin were observed in the cell and medium fractions from neutrophils. P-LPS increased calprotectin release from seven to 16 times the control level after 30 min and its effect appeared in a dose-dependent manner (10-1000 ng/ml). Lipopolysaccharides from A. actinomycetemcomitans, P. intermedia, F. nucleatum, and E. coli also induced calprotectin release from neutrophils. These results suggest that lipopolysaccharides from periodontopathic bacteria induce calprotectin release from human neutrophils.
Kido
J
J
Department of Periodontology and Endodontology, Tokushima University School of Dentistry, Tokushima, Japan. kido@dent.tokushima-u.ac.jp
Kido
R
R
Suryono
Kataoka
M
M
Fagerhol
M K
MK
Nagata
T
T
D000328:Adult; D016976:Aggregatibacter actinomycetemcomitans; D015415:Biomarkers / Q000032:analysis; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D004926:Escherichia coli; D016967:Fusobacterium nucleatum; D005883:Gingival Crevicular Fluid / Q000737:chemistry; D006801:Humans; D015151:Immunoblotting; D039841:Leukocyte L1 Antigen Complex / Q000032:analysis / Q000187:drug effects*; D008070:Lipopolysaccharides / Q000494:pharmacology*; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D010518:Periodontitis / Q000378:metabolism; D016966:Porphyromonas gingivalis; D018713:Prevotella intermedia; D013997:Time Factors
D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex; D008070:Lipopolysaccharides